Based on our TSPAN8 work in the context of cancer (Nazarenko et al., 2010; Voglstaetter et al., 2019), we propose that TSPAN8 as a potential therapeutic target for controlling the severity of COVID-19 disease. This evidence concerns the gene TSPAN8 and cancer.